Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H23NO4.ClH |
| Molecular Weight | 377.862 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC=C2C[C@@H]3[C@@H]4CC=C(OC(C)=O)[C@@H]5OC1=C2[C@]45CCN3C
InChI
InChIKey=OTQDEDKVELDPIY-ZKVYEUBZSA-N
InChI=1S/C20H23NO4.ClH/c1-11(22)24-16-7-5-13-14-10-12-4-6-15(23-3)18-17(12)20(13,19(16)25-18)8-9-21(14)2;/h4,6-7,13-14,19H,5,8-10H2,1-3H3;1H/t13-,14+,19-,20-;/m0./s1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C20H23NO4 |
| Molecular Weight | 341.4009 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://books.google.ru/books?id=PcyoOmjvGzkC&printsec=frontcover&hl=ru#v=onepage&q&f=falseCurator's Comment: Description was created based on several sources, including
https://books.google.ru/books?id=szDnBwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=false | https://www.boehringer-ingelheim.us/history/history-milestone/1885-1948 | https://www.ncbi.nlm.nih.gov/pubmed/23440583
Sources: https://books.google.ru/books?id=PcyoOmjvGzkC&printsec=frontcover&hl=ru#v=onepage&q&f=false
Curator's Comment: Description was created based on several sources, including
https://books.google.ru/books?id=szDnBwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=false | https://www.boehringer-ingelheim.us/history/history-milestone/1885-1948 | https://www.ncbi.nlm.nih.gov/pubmed/23440583
Thebacon (dihydrocodeinone enol acetate, trade name Acedicon) is semisynthetic opioid analgetic and antitussive compound. Boehringer-Ingelheim merketed Acedicon for the treatment of cough. Thebacon is a Schedule I drug, that has not got approved use in US.
Originator
Sources: https://www.google.com/patents/US1731152
Curator's Comment: reference retrived from https://books.google.ru/books?id=_J2ti4EkYpkC&printsec=frontcover&hl=ru#v=onepage&q&f=false | https://www.boehringer-ingelheim.us/history/history-milestone/1885-1948
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3180 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25445008 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | ACEDICON Approved UseAntitussive Launch Date1928 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Contribution of human esterases to the metabolism of selected drugs of abuse. | 2015-01-05 |
|
| A comparison of the antinociceptive and temperature responses to morphine and fentanyl derivatives in rats. | 2013-04 |
|
| [Clinical experiences with acedicon tablongettes]. | 1960-03-26 |
|
| [Acute acedicon poisoning; recovery with nalorphine]. | 1958-01-01 |
|
| [Acedicon in the symptomatic therapy of pulmonary tuberculosis]. | 1951-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:24:34 GMT 2025
by
admin
on
Mon Mar 31 22:24:34 GMT 2025
|
| Record UNII |
65Y58V95HC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
65Y58V95HC
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
100000084800
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
20236-82-2
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
m10696
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB04769MIG
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
DTXSID60942351
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
12443397
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY | |||
|
243-623-5
Created by
admin on Mon Mar 31 22:24:34 GMT 2025 , Edited by admin on Mon Mar 31 22:24:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |